Phio Pharmaceuticals Corp. (PHIO) ownership: Top institutional holder: GEODE CAPITAL MANAGEMENT, LLC ($179649.00). Insider activity: Net Seller (7 buys, 13 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 147254.00 | $179649.00 | 2026-03-31 |
| JANE STREET GROUP, LLC | 119189.00 | $145410.00 | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 79853.00 | $97421.00 | 2026-03-31 |
| VANGUARD GROUP INC | 87628.00 | $92009.00 | 2025-12-31 |
| CITADEL ADVISORS LLC | 44526.00 | $80147.00 | 2024-12-31 |
| Cetera Investment Advisers | 45000.00 | $54900.00 | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 38169.00 | $46566.00 | 2026-03-31 |
| HRT FINANCIAL LP | 34732.00 | $42000.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-08-19 | |
| Buy | null | 2026-08-18 | |
| Buy | null | 2026-06-26 | |
| Sell | null | 2026-02-05 | |
| Sell | null | 2026-02-05 | |
| Sell | null | 2026-02-05 | |
| Sell | null | 2026-02-05 | |
| Sell | null | 2026-02-05 |
Back to PHIO overview · PHIO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.